Centiva Capital’s scPharmaceuticals SCPH Stock Holding History

Centiva Capital’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,865	Closed	-$107K	–	1555
2025 Q3	$107K	Buy	+18,865	New	+$96.6K	﹤0.01%	900

Centiva Capital's SCPH Position: Q4 2025 in Review

Centiva Capital sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 18,865 shares — an estimated $107K sold.

Centiva Capital first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $107K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Centiva Capital reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Centiva Capital sold 18,865 scPharmaceuticals shares in Q4 2025, an estimated $107K.
Centiva Capital first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
Centiva Capital's scPharmaceuticals position peaked at $107K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Centiva Capital's 13F filing for Q4 2025, filed 13 Feb 2026.